Back to Search
Start Over
The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithmof the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort.
- Source :
- European Journal of Preventive Cardiology; Jan2021, Vol. 28 Issue 1, p47-56, 10p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 20474873
- Volume :
- 28
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- European Journal of Preventive Cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 152593497
- Full Text :
- https://doi.org/10.1093/eurjpc/zwaa088